Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group study.

Clark JI, Mehrabi J, Sosman JA, Logan TF, Margolin KA, Dutcher JP, Urba WJ, Ernstoff MS, McDermott DF, Lau AM, Atkins MB
J Immunother. 2007 30 (8): 839-46

PMID: 18049336 · DOI:10.1097/CJI.0b013e3181587977

MeSH Terms (20)

Acute Kidney Injury Adult Aged Antineoplastic Combined Chemotherapy Protocols Carcinoma, Renal Cell Cardiomyopathies Dose-Response Relationship, Drug Female Humans Interferon-alpha Interferon alpha-2 Interleukin-2 Kidney Neoplasms Male Middle Aged Outpatients Polyethylene Glycols Recombinant Proteins Survival Analysis Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: